OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Management of Chronic Lymphocytic Leukemia in 2020

EP. 1: Prognostic Factors in Patients With CLL

January 28th 2020

EP. 2: Mutation Status Throughout the CLL Clinical Course

January 28th 2020

EP. 3: Chemoimmunotherapy for CLL; Still a Role?

January 28th 2020

EP. 4: Long-Term Experience With BTK Inhibitors for CLL

January 28th 2020

EP. 5: Acalabrutinib, Second-Generation BTK Inhibitor for CLL

January 28th 2020

EP. 6: The Role of Venetoclax + Rituximab in CLL

January 28th 2020

EP. 7: Treatment for Younger Fit Patients With CLL

January 28th 2020

EP. 8: Ibrutinib + Venetoclax for CLL

January 28th 2020

EP. 9: Combining Targeted Therapies in CLL

January 28th 2020

EP. 10: Distinguishing Features Among BTK Inhibitors

January 28th 2020

EP. 11: Health Maintenance in CLL

January 28th 2020

EP. 12: Fixed-Duration Therapy for Relapsed CLL

January 28th 2020

EP. 13: Combinations for Relapsed or Refractory CLL

January 28th 2020

EP. 14: Resistance to Therapy in CLL

January 28th 2020

EP. 15: Management of CLL Progression After Ibrutinib

January 28th 2020

EP. 16: PI3 Kinase Inhibitors for Relapsed/Refractory CLL

January 28th 2020

EP. 17: Sequencing Strategies for CLL

January 28th 2020

EP. 18: CAR T-Cell Therapy for Relapsed/Refractory CLL

January 28th 2020

EP. 19: 2019 ASH; Best Abstracts for CLL

January 28th 2020